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Abstract
Since its launch at the beginning of 2005, Molecular Pain has published pain research articles that
cover broad areas including: genetics, molecular and cellular biology, synaptic and neuronal
mechanisms, novel animal models and human functional imaging studies. One important feature of
Molecular Pain is its high speed in manuscript processing and publication, making the journal one of
the best places for pain researchers to publish their novel findings.
Editorial
The new year of 2007 marks the two-year anniversary of
Molecular Pain. We take this opportunity to wish our
authors and readers a productive and successful new year,
and we hope you will be with Molecular Pain in the com-
ing years. We thank reviewers and editorial board mem-
bers of Molecular Pain for your strong support. Your
contribution, support, and suggestion will remain to be
important for Molecular Pain in the coming years. Molec-
ular pain research field is expanding and publication with
our journal will become more active.
Two years ago, in the preparation for launching Molecular
Pain, some pain researchers questioned whether we were
indeed in the era of "molecular pain" and whether Molec-
ular Pain was an appropriate title for this journal. Instead
of waiting for a complete answer, Molecular Pain editors
went ahead set up the platform for our pain researchers
who share the same vision with us. Over the past two
years, Molecular Pain has published papers that covered
pain topics from genetics, molecular biology, synaptic
mechanism, to novel animal models and human func-
tional imaging studies. Molecular Pain is now recognized
by many pain researchers and neuroscientists as an effec-
tive forum for communicating their novel research find-
ings. The effectiveness comes from our online publication
in a timely fashion and the open access to everyone
around the world without any barrage.
The publication punctuality is essential for researchers
who have novel findings in today's highly competitive
"research market". Molecular Pain reviewers, editors and
BMC have been working hard and making every effort to
ensure timely processing and publishing papers that are
submitted to Molecular Pain. Powered by BMC online sys-
tem for manuscript processing, publication speed of
Molecular Pain is ranked on the top list among peer-review
scientific journals. In average, it only takes 60 days from
receiving a manuscript to its publication online in Molec-
ular Pain. On the other hand, professional journals such as
Pain will take about 180 days to publish a manuscript,
about 3 times longer than Molecular Pain (see Figure 1).
We will continue to let authors enjoy rapid publication
with Molecular Pain in 2007 and further reduce processing
time for papers with high novelty.
Submission to Molecular Pain is growing over the past two
years. In the year 2005, about 40% of papers were solic-
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ited submission. However, in 2006, over 90% of papers
were unsolicited submission. Submission now comes
from both well-known pain research groups as well as
from new investigators from different countries and
regions. We are pleased to see multiple submissions from
same research groups, which show their trust and satisfac-
tion to Molecular Pain.
Many articles published in Molecular Pain have been "hit"
for over thousands of times by readers over a relatively
short time period following their publication. This indi-
cates that articles published in Molecular Pain gain high
access and readership, promising a high impact in the
near future. Indeed, a number of articles published in
Molecular Pain have been highly cited in literature in less
than two years of their publication. The rate of citation for
these articles published in Molecular Pain is comparable to
papers published in well established journal such as Jour-
nal of Neuroscience. This clearly shows the advantage of
open access and online publication with Molecular Pain.
Molecular Pain has been continuously tracked by PubMed
and Medline since its launch at the beginning of 2005.
Because of the steady growth and good quality of papers
published in Molecular Pain, ISI has recently approved for
tracking Molecular Pain publications for official impact
factor, which will be announced as a public record in two
years.
Over the past two years we have received a number of
requests from pain researchers and neuroscientists around
the world who are interested in joining the Molecular Pain
editorial board. We have expanded the editorial board to
strengthen the research area including ion channels and
brain imaging. We once again thank those who are volun-
tarily coming up to serve as editorial board member to
strengthen Molecular Pain. Several other areas such as
human genetics, clinical pain research, and drug discover-
ies remain to be strengthened in the Molecular Pain edito-
rial board. We will welcome pain researchers with
expertise in these areas to join the editorial board. Please
contact us if you are interested in joining us to expand
molecular pain research field.
In addition to our main focus on publication, Molecular
Pain has sponsored "The First International Conference of
Memory, Synapses, and Pain" held in Toronto in the
August of 2006. The meeting abstract has been published
online in Molecular Pain. Molecular Pain will continue to
sponsor this meeting, which will be held again in the fall
of 2007 in Toronto. Publication of meeting abstracts with
Molecular Pain provides a useful record. Molecular Pain will
provide this platform for other pain-related meetings, and
we welcome meeting organizers to contact Molecular Pain
editors for an arrangement to publish meeting abstract
and other related information.
Over the past two years, contributors to Molecular Pain
have enjoyed low introductory publication charges
offered by our publisher BMC. BMC has recently
requested to adjust the publication charge comparable to
other online journals. After our negotiation with BMC,
the change of publication charges will be modest and we
will continue to enjoy a relatively low publication cost
compared with other online journals in BMC.
In conclusion, Molecular Pain has achieved its primary
goal in the first two years. We will continue to provide the
best service to our authors and readers, making Molecular
Pain a high-impact scientific journal.
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